vTv Therapeutics Inc. - (VTVT) share price
vTv Therapeutics Inc. - (NASDAQ:VTVT) last traded at $21.03, down 3.27% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.08B and a 52-week range of $20.56 to $44.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $21.03 |
| 1-day move | -3.27% |
| 52-week range | $20.56 - $44 |
| Market cap | $0.08B |
| From 52-week high | -52.20% |
| Volume vs average | 0.4x |
| Falling Shares risk score | 46/100 (ELEVATED) |
| Country | United States |
Frequently asked questions
Why is vTv Therapeutics Inc. - falling today?
vTv Therapeutics Inc. - (NASDAQ:VTVT) is down 3.27% at its latest quote and trades 52.2% below its 52-week high, at a new 52-week low. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the vTv Therapeutics Inc. - share price today?
vTv Therapeutics Inc. - (NASDAQ:VTVT) last traded at $21.03, a -3.27% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of vTv Therapeutics Inc. -?
vTv Therapeutics Inc. -'s 52-week low is $20.56 and its 52-week high is $44; the shares trade 52.2% below the high.
What is the market cap of vTv Therapeutics Inc. -?
vTv Therapeutics Inc. - has a market capitalisation of about $0.08B at the latest price.
What are the risks of investing in vTv Therapeutics Inc. -?
Falling Shares Intelligence rates vTv Therapeutics Inc. - 46/100 (ELEVATED) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com